BioRestorative Therapies, Inc. (BRTX) — key financial figures for fiscal year 2025 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:

Revenue (FY2025)

$359.7K

Net Income/Loss (FY2025)

-$14.2M

Total Assets (FY2025)

$4.1M

Total Equity (FY2025)

$356.7K

Cash Flows from Operating Activities (FY2025)

-$10.8M

Source: BioRestorative Therapies, Inc. 10-K filing (FY2025). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.